Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | BMC Cancer | journal | 1.137 Q2 | 149 | 1345 | 3781 | 54333 | 16111 | 3780 | 3.72 | 40.40 | |
2 | Cell Death and Disease | journal | 2.188 Q1 | 147 | 1032 | 3036 | 54768 | 27301 | 3000 | 8.36 | 53.07 | |
3 | Cancer Medicine | journal | 1.188 Q2 | 75 | 592 | 2399 | 24500 | 10520 | 2393 | 3.89 | 41.39 | |
4 | Cancer Cell International | journal | 1.145 Q2 | 70 | 411 | 1581 | 28309 | 8952 | 1579 | 5.53 | 68.88 | |
5 | Oncogene | journal | 2.311 Q1 | 360 | 439 | 1522 | 22776 | 11777 | 1513 | 7.36 | 51.88 | |
6 | Journal for ImmunoTherapy of Cancer | journal | 3.403 Q1 | 100 | 537 | 1397 | 20980 | 14294 | 1385 | 8.88 | 39.07 | |
7 | European Journal of Cancer | journal | 2.898 Q1 | 235 | 806 | 1354 | 15826 | 9192 | 1085 | 6.15 | 19.64 | |
8 | Future Oncology | journal | 0.874 Q2 | 84 | 386 | 1152 | 15259 | 3340 | 1081 | 2.86 | 39.53 | |
9 | Journal of Experimental and Clinical Cancer Research | journal | 2.413 Q1 | 107 | 334 | 1077 | 21191 | 11596 | 1075 | 9.38 | 63.45 | |
10 | British Journal of Cancer | journal | 2.867 Q1 | 259 | 433 | 1195 | 21677 | 9529 | 1038 | 7.60 | 50.06 | |
11 | Leukemia and Lymphoma | journal | 0.837 Q3 | 99 | 478 | 1553 | 14075 | 2564 | 939 | 1.65 | 29.45 | |
12 | Leukemia | journal | 3.376 Q1 | 211 | 344 | 1098 | 13725 | 8402 | 895 | 7.59 | 39.90 | |
13 | Oral Oncology | journal | 1.271 Q2 | 128 | 467 | 1193 | 10387 | 4026 | 747 | 3.00 | 22.24 | |
14 | Molecular and Clinical Oncology | journal | 0.393 Q4 | 16 | 156 | 605 | 5238 | 891 | 604 | 1.26 | 33.58 | |
15 | Japanese Journal of Clinical Oncology | journal | 0.743 Q3 | 93 | 200 | 670 | 4497 | 1599 | 596 | 1.99 | 22.49 | |
16 | Cell Death Discovery | journal | 1.545 Q1 | 49 | 488 | 595 | 24105 | 3863 | 578 | 6.58 | 49.40 | |
17 | International Journal of Hyperthermia | journal | 0.762 Q3 | 92 | 161 | 561 | 6613 | 1910 | 541 | 3.00 | 41.07 | |
18 | ESMO Open | journal | 2.196 Q1 | 49 | 254 | 583 | 8738 | 3300 | 503 | 5.73 | 34.40 | |
19 | Signal Transduction and Targeted Therapy | journal | 6.630 Q1 | 83 | 392 | 779 | 40286 | 14639 | 480 | 18.94 | 102.77 | |
20 | Carcinogenesis | journal | 1.071 Q2 | 218 | 101 | 492 | 2903 | 2012 | 476 | 4.45 | 28.74 | |
21 | ecancermedicalscience | journal | 0.665 Q3 | 42 | 151 | 470 | 6324 | 1068 | 467 | 1.85 | 41.88 | |
22 | Journal of the National Cancer Institute | journal | 5.409 Q1 | 377 | 256 | 656 | 6552 | 4987 | 463 | 6.92 | 25.59 | |
23 | Neuro-Oncology | journal | 4.833 Q1 | 150 | 254 | 715 | 5645 | 6916 | 451 | 9.53 | 22.22 | |
24 | Journal of Hematology and Oncology | journal | 6.046 Q1 | 122 | 171 | 500 | 18367 | 11243 | 436 | 20.88 | 107.41 | |
25 | Molecular Cancer | journal | 8.703 Q1 | 171 | 210 | 484 | 17736 | 17050 | 436 | 28.85 | 84.46 | |
26 | Molecular Therapy - Oncolytics | journal | 1.339 Q2 | 34 | 154 | 422 | 9805 | 2377 | 422 | 5.56 | 63.67 | |
27 | Epigenomics | journal | 0.809 Q3 | 71 | 120 | 429 | 6639 | 1456 | 401 | 3.09 | 55.33 | |
28 | Breast Cancer Research | journal | 2.408 Q1 | 167 | 100 | 395 | 4834 | 2987 | 389 | 6.91 | 48.34 | |
29 | Journal of Oral Pathology and Medicine | journal | 0.682 Q3 | 91 | 120 | 400 | 3854 | 1575 | 382 | 3.39 | 32.12 | |
30 | Cancer Treatment and Research Communications | journal | 0.674 Q3 | 18 | 152 | 357 | 6582 | 912 | 338 | 2.52 | 43.30 | |
31 | Endocrine-Related Cancer | journal | 1.255 Q2 | 140 | 74 | 310 | 3070 | 1409 | 302 | 3.66 | 41.49 | |
32 | Leukemia Research | journal | 0.673 Q3 | 93 | 124 | 431 | 4336 | 783 | 295 | 1.78 | 34.97 | |
33 | Prostate Cancer and Prostatic Diseases | journal | 1.676 Q1 | 74 | 190 | 317 | 5897 | 1516 | 285 | 4.63 | 31.04 | |
34 | Hematological Oncology | journal | 1.051 Q2 | 50 | 157 | 344 | 5264 | 956 | 270 | 2.19 | 33.53 | |
35 | Cancer Reports | journal | 0.513 Q4 | 14 | 251 | 245 | 8432 | 513 | 239 | 2.07 | 33.59 | |
36 | Cancer Gene Therapy | journal | 1.384 Q2 | 95 | 202 | 236 | 10566 | 1430 | 227 | 6.29 | 52.31 | |
37 | Molecular and Cellular Oncology | journal | 0.436 Q4 | 34 | 17 | 312 | 392 | 340 | 220 | 1.04 | 23.06 | |
38 | FASEB BioAdvances | journal | 0.731 Q3 | 15 | 59 | 209 | 3156 | 590 | 201 | 2.82 | 53.49 | |
39 | Cancer Communications | journal | 2.677 Q1 | 69 | 110 | 260 | 6255 | 2613 | 186 | 9.77 | 56.86 | |
40 | Infectious Agents and Cancer | journal | 0.583 Q3 | 42 | 61 | 186 | 3193 | 668 | 182 | 3.51 | 52.34 | |
41 | Nature Reviews Cancer | journal | 20.977 Q1 | 484 | 111 | 325 | 8402 | 10528 | 174 | 37.34 | 75.69 | |
42 | npj Precision Oncology | journal | 2.520 Q1 | 30 | 94 | 166 | 5100 | 1326 | 163 | 7.38 | 54.26 | |
43 | Seminars in Radiation Oncology | journal | 1.389 Q2 | 98 | 52 | 128 | 3710 | 590 | 119 | 3.38 | 71.35 | |
44 | Advances in Biological Regulation | journal | 1.276 Q2 | 67 | 30 | 123 | 1710 | 528 | 117 | 3.86 | 57.00 | |
45 | Experimental Hematology and Oncology | journal | 1.908 Q1 | 35 | 106 | 126 | 7331 | 967 | 107 | 8.65 | 69.16 | |
46 | European Journal of Cancer, Supplement | journal | 0.571 Q3 | 28 | 0 | 14 | 0 | 27 | 13 | 1.93 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®